{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:55:53Z","timestamp":1785426953086,"version":"3.56.0"},"reference-count":34,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["22H03366"],"award-info":[{"award-number":["22H03366"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["20H03957"],"award-info":[{"award-number":["20H03957"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["23K09770"],"award-info":[{"award-number":["23K09770"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["23592459"],"award-info":[{"award-number":["23592459"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["26861338"],"award-info":[{"award-number":["26861338"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"award":["22H03366"],"award-info":[{"award-number":["22H03366"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"publisher"}]},{"award":["20H03957"],"award-info":[{"award-number":["20H03957"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"publisher"}]},{"award":["23K09770"],"award-info":[{"award-number":["23K09770"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"publisher"}]},{"award":["23592459"],"award-info":[{"award-number":["23592459"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"publisher"}]},{"award":["26861338"],"award-info":[{"award-number":["26861338"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Epithelial ovarian cancer (EOC) is characterized by aggressive peritoneal dissemination and an immunosuppressive tumor microenvironment in which tumor-associated macrophages (TAMs) play a central role. Chemokine signaling pathways regulate macrophage recruitment and function; however, the contribution of the CX3CL1\u2013CX3CR1 axis to ovarian cancer progression and TAM-mediated effector mechanisms remains unclarified. This study aimed to clarify the role of CX3CL1\u2013CX3CR1 signaling in ovarian cancer progression, focusing on macrophage-derived pro-tumorigenic factors. Methods: CX3CL1 and CX3CR1 expression was examined in human EOC and healthy ovarian tissues by real-time polymerase chain reaction and immunohistochemistry. Functional effects of CX3CL1 on ovarian cancer cells were evaluated via migration and proliferation assays in the murine ID8 cell line. An intraperitoneal syngeneic ovarian cancer model was established by injecting ID8 cells into wild-type and Cx3cr1-deficient mice. Tumor burden, ascites formation, survival, macrophage infiltration, and expression levels of matrix metalloprotease-2 (MMP-2) and transforming growth factor-\u03b2 (TGF-\u03b2) were assessed by histological, immunohistochemical, and molecular analyses. Results: CX3CL1 and CX3CR1 expression was significantly upregulated in human EOC tissues and associated with marked macrophage infiltration. CX3CL1 stimulation enhanced migration, but not proliferation, of ID8 cells. Cx3cr1 deficiency significantly suppressed intraperitoneal tumor growth, reduced ascitic fluid volume, and prolonged survival. This was accompanied by reduced CX3CR1+ TAM accumulation and decreased MMP-2 and TGF-\u03b2 expression, which were predominantly produced by infiltrating macrophages. Conclusions: The CX3CL1\u2013CX3CR1 axis promotes ovarian cancer progression by recruiting MMP-2- and TGF-\u03b2-producing macrophages. Targeting CX3CR1-dependent TAM functions may represent a therapeutic strategy for limiting peritoneal dissemination in ovarian cancer.<\/jats:p>","DOI":"10.3390\/cancers18111855","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:10:42Z","timestamp":1780668642000},"page":"1855","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CX3CR1-Dependent Macrophages Drive Ovarian Cancer Progression Through MMP-2 and TGF-\u03b2 Production"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1813-1629","authenticated-orcid":false,"given":"Yuko","family":"Tanizaki-Horiuchi","sequence":"first","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, Wakayama 641-8509, Japan"},{"name":"Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6104-7599","authenticated-orcid":false,"given":"Yuko","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0208-5420","authenticated-orcid":false,"given":"Tamaki","family":"Yahata","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Kuninaka","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2103-2469","authenticated-orcid":false,"given":"Saori","family":"Toujima","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuho","family":"Nosaka","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Matsuki","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Mizoguchi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naofumi","family":"Mukaida","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Ino","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5059-8309","authenticated-orcid":false,"given":"Toshikazu","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Wakayama Medical University, Wakayama 641-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13048-022-01020-1","article-title":"Maintenance therapy for newly diagnosed epithelial ovarian cancer\u2013a review","volume":"15","author":"Nag","year":"2022","journal-title":"J. Ovarian Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","article-title":"Niraparib in patients with newly diagnosed advanced ovarian cancer","volume":"381","author":"Pothuri","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdz135","article-title":"Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: Results from the phase II KEYNOTE-100 study","volume":"30","author":"Matulonis","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cyto.2012.01.015","article-title":"Inflammation and ovarian cancer","volume":"58","author":"Madeddu","year":"2012","journal-title":"Cytokine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(26)00602-1","article-title":"Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65\/KEYNOTE-B96): A multicentre, randomised, double-blind, phase 3 study","volume":"407","author":"Colombo","year":"2026","journal-title":"Lancet"},{"key":"ref_6","first-page":"861","article-title":"Components of the hepatocellular carcinoma microenvironment and their role in tumor progression","volume":"82","author":"Novikova","year":"2017","journal-title":"Biochemistry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1084\/jem.20150295","article-title":"The interaction of anticancer therapies with tumor-associated macrophages","volume":"212","author":"Mantovani","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13550-024-01157-8","article-title":"Imaging tumor and ascites-associated macrophages in a mouse model of metastatic ovarian cancer","volume":"14","author":"Foss","year":"2024","journal-title":"EJNMMI Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1002\/cam4.2327","article-title":"Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1541-7786.MCR-11-0256","article-title":"Fractalkine receptor CX3CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells","volume":"10","author":"Kim","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1757-2215-7-19","article-title":"A high M1\/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients","volume":"7","author":"Zhang","year":"2014","journal-title":"J. Ovarian Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"He, Y.-F., Zhang, M.-Y., Wu, X., Sun, X.-J., Xu, T., He, Q.-Z., and Di, W. (2013). High MUC2 Expression in ovarian cancer is inversely associated with the M1\/M2 ratio of tumor-associated macrophages and patient survival time. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079769"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/onc.2013.191","article-title":"Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression","volume":"33","author":"Comito","year":"2014","journal-title":"Oncogene"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jss.2009.05.026","article-title":"Significance of M2-polarized tumor-associated macrophage in pancreatic cancer","volume":"167","author":"Kurahara","year":"2011","journal-title":"J. Surg. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: Positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1038\/onc.2016.456","article-title":"Emergent role of the fractalkine axis in dissemination of peritoneal metastasis from epithelial ovarian carcinoma","volume":"36","author":"Xie","year":"2017","journal-title":"Oncogene"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.3390\/biom5043438","article-title":"Examination of the fractalkine and fractalkine receptor expression in fallopian adenocarcinoma reveals differences when compared to ovarian carcinoma","volume":"5","author":"Gurler","year":"2015","journal-title":"Biomolecules"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.jid.2020.02.023","article-title":"Pivotal Involvement of the CX3CL1-CX3CR1 Axis for the Recruitment of M2 Tumor-Associated Macrophages in Skin Carcinogenesis","volume":"140","author":"Ishida","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1593\/neo.09228","article-title":"Phenotypic and functional delineation of murine CX3CR1 monocyte-derived cells in ovarian cancer","volume":"11","author":"Hart","year":"2009","journal-title":"Neoplasia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbcan.2012.12.007","article-title":"Recruitment of monocytes\/macrophages in different tumor microenvironments","volume":"1835","author":"Lee","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Boutilier, A.J., and Elsawa, S.F. (2021). Macrophage polarization states in the tumor microenvironment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136995"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: From development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4049\/jimmunol.180.1.569","article-title":"Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function","volume":"180","author":"Ishida","year":"2008","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1038\/s41467-020-19763-0","article-title":"Prevention of CaCl2-induced aortic inflammation and subsequent aneurysm formation by the CCL3\u2013CCR5 axis","volume":"11","author":"Ishida","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1158\/0008-5472.CAN-12-3828","article-title":"CX3CL1 promotes breast cancer via transactivation of the EGF pathway","volume":"73","author":"Mira","year":"2013","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/neuonc\/nop076","article-title":"CX3CR1\/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-\u03b21","volume":"12","author":"Soriani","year":"2010","journal-title":"Neuro-Oncology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1158\/1541-7786.MCR-16-0013","article-title":"Novel small-molecule CX3CR1 antagonist impairs metastatic seeding and colonization of breast cancer cells","volume":"14","author":"Shen","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16833","DOI":"10.1038\/s41598-017-17007-8","article-title":"Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration","volume":"7","author":"Ishida","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"Roby","year":"2000","journal-title":"Carcinogenesis"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Loh, S.X., Ekinci, Y., Spray, L., Jeyalan, V., Olin, T., Richardson, G., Austin, D., Alkhalil, M., and Spyridopoulos, I. (2023). Fractalkine Signalling (CX3CL1\/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease. J. Clin. Med., 12.","DOI":"10.3390\/jcm12144821"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2355684","DOI":"10.1080\/2162402X.2024.2355684","article-title":"Peripheral CX3CR1+ T cells combined with PD-1 blockade therapy potentiates the anti-tumor efficacy for lung cancer","volume":"13","author":"Li","year":"2024","journal-title":"OncoImmunology"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1855\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:19:04Z","timestamp":1780978744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cancers18111855"],"URL":"https:\/\/doi.org\/10.3390\/cancers18111855","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}